A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF

Enrolling by invitationOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

January 30, 2027

Conditions
Atrial Fibrillation
Interventions
DEVICE

Pulsed Field Ablation

Ablation using the Boston Scientific Farapulse Pulsed Field Ablation System for the treatment of atrial fibrillation (AF)

Trial Locations (25)

15212

Allegheny General Hospital, Pittsburgh

17402

WellSpan Health, York

23225

HCA Research Institute - Chippenham Hospital, Richmond

28801

HCA Research Institute Mission Hospital, Asheville

29406

HCA - Trident Medical Center, North Charleston

32204

Ascension St. Vincent's, Jacksonville

33133

HCA Florida Mercy Hospital, Miami

33484

The Arrythmia Center of South Florida, Delray Beach

34239

Sarasota Memorial Hospital, Sarasota

35243

Arrhythmia Institute at Grandview, Birmingham

37203

Ascension St. Thomas Nashville, Nashville

40205

Norton Heart & Vascular Institute, Louisville

43214

OhioHealth Research Institute, Columbus

45219

The Christ Hospital - Heart & Vascular, Cincinnati

The Christ Hospital, Cincinnati

46184

Ascension St Vincent -Indianapolis Ascension Healt, Indianapolis

50026

MercyOne Iowa Heart Center, West Des Moines

60026

Endeavor Health (Northshore), Glenview

72401

Arrhythmia Research Group, Jonesboro

78705

Ascension Texas Cardiovascular, Austin

Texas Cardiac Arrhythmia Research Foundation (St. Davids), Austin

84124

St. Mark's Hospital, Salt Lake City

93003

Community Memorial Health Systems, Ventura

02115

Brigham and Women's Hospital, Boston

08035

Cardiovascular Associates of Delaware Valley, Haddon Heights

All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Heart Rhythm Clinical and Research Solutions, LLC

OTHER